The Role of E‑Cadherin as a Prognostic Biomarker in Head and Neck Squamous Carcinoma: A Systematic Review and Meta‑Analysis

The Role of E‑Cadherin as a Prognostic Biomarker in Head and Neck Squamous Carcinoma: A Systematic Review and Meta‑Analysis


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: جواد یزدانی , محمدعلی قویمی , الهه جباری حق , فرزین احمدپورپورناکی

کلمات کلیدی: -

نشریه: 24420 , 5 , 22 , 2018

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله محمدعلی قویمی
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه دانشکده دندانپزشکی
کد مقاله 64976
عنوان فارسی مقاله The Role of E‑Cadherin as a Prognostic Biomarker in Head and Neck Squamous Carcinoma: A Systematic Review and Meta‑Analysis
عنوان لاتین مقاله The Role of E‑Cadherin as a Prognostic Biomarker in Head and Neck Squamous Carcinoma: A Systematic Review and Meta‑Analysis
ناشر 4
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ خیر
عنوان نشریه (خارج از لیست فوق)
نوع مقاله Review Article
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت

خلاصه مقاله
hide/show

Abstract Purpose In this study, we systematically investigated and analyzed articles focusing on the prognostic value of E-cadherin (E-cad) in human head and neck squamous cell carcinoma (HNSCC). Methods Searching through the diferent databases, the studies examining the associations between E-cad and HNSCC prognosis were identifed. Outcomes such as disease-specifc survival and overall survival were considered acceptable. Hazard ratio (HR) with 95% confdence interval (CI) was used to demonstrate prognostic value. Results A total of 40 studies were systematically analyzed, and fnally, 1939 subjects were included in our meta-analysis. Our fndings showed that signifcant aberrant expression of E-cad was associated with poor survival. However, some studies showed increased expression of E-cad in metastatic lesions was associated with poor prognosis. Alteration in location of E-cad expression also showed signifcant association with cancer survival, i.e., increased cytoplasmic E-cad. We conducted a meta-analysis on the eligible articles using a random efect model because of moderate heterogeneity. Strong association between aberrant expression of E-cad and poor survival was demonstrated (pooled HR=2.28; 95% CI 1.78–2.91). Conclusions Aberrant expression of E-cad may be a promising prognostic signature for HNSCC, especially when it is used with other prognostic markers.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
جواد یزدانیاول
محمدعلی قویمیدوم
الهه جباری حقسوم
فرزین احمدپورپورناکیچهارم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
4_5847931404700091516.pdf1397/09/131341998دانلود